Pennsylvania Senator John Fetterman is giving President Donald Trump something Democrats rarely hand out these days: credit.
In a recent interview, Fetterman praised the Trump administration’s moves toward marijuana reform and expanded access to psychedelic therapies, saying, “I think we could all agree [on] everything that President Trump has done about liberalizing marijuana and psychedelics.”
That’s a pretty remarkable statement in today’s political climate, especially coming from one of the Senate’s most outspoken progressive voices on cannabis legalization.
Fetterman has supported legal weed for years, long before it became politically fashionable. During his time as Pennsylvania’s lieutenant governor, he toured all 67 counties in the state pushing for marijuana legalization and openly criticized prohibition-era policies.
Now, with the Trump administration moving forward on federal marijuana rescheduling and showing growing openness toward psychedelic-assisted therapy research, the cannabis debate is getting harder to frame as strictly left versus right.
That doesn’t mean everyone is suddenly aligned. The administration still sends mixed messages on drug policy. Trump has backed marijuana rescheduling efforts while also making harsh comments about illegal narcotics and fentanyl trafficking.
Still, the bigger takeaway may be this: cannabis reform has crossed into politically strange territory where libertarians, veterans groups, younger conservatives, progressives, and parts of the business community are all finding overlapping interests.
A decade ago, bipartisan praise like this would’ve sounded impossible.
In 2026, it barely surprises anyone anymore.
Dabbin-Dad Newsroom
